Financial Performance - Revenue for the six months ended June 30, 2025, decreased by 9% to approximately HKD 122.8 million compared to HKD 135.3 million in 2024[13] - Profit attributable to owners of the company for the same period fell by 56% to approximately HKD 8.2 million from HKD 18.5 million in 2024[13] - Basic and diluted earnings per share decreased to HKD 0.58 from HKD 1.31, representing a 56% decline[5] - The group's total revenue decreased by 9% to approximately HKD 122,800,000 for the six months ended June 30, 2025, compared to approximately HKD 135,300,000 in the same period of 2024[16] - The total number of bottles sold during the period decreased to approximately 4.8 million, down from approximately 5.2 million in 2024[16] - Gross profit for the same period was HKD 47,277,000, down from HKD 48,767,000, reflecting a decline of 3.1%[77] - Operating profit decreased significantly to HKD 7,462,000, compared to HKD 17,044,000 in the previous year, representing a decline of 56.2%[77] - The company reported a profit of HKD 7,729,000 for the six months ended June 30, 2025, a decrease of 57.0% compared to HKD 17,978,000 in the same period of 2024[80] - Total comprehensive income for the period was HKD 13,432,000, down from HKD 15,359,000 year-on-year, reflecting a decline of 12.5%[80] Cost and Expenses - Increased promotional and advertising expenses contributed to the decline in operating profit during the first half of 2025[14] - Distribution costs accounted for approximately 23% of the group's revenue, up from 16% in 2024, attributed to increased marketing resources[24] - Management expenses represented 15% of the group's revenue, an increase from 11% in 2024, due to rising employee and related costs[25] - Distribution costs increased to HKD 27,855,000 from HKD 21,442,000, an increase of 29.9%[77] - Management expenses rose to HKD 17,966,000, compared to HKD 14,307,000, an increase of 25.5%[77] Financial Stability - The total equity attributable to owners of the company increased to HKD 318.5 million from HKD 310.0 million[5] - The debt-to-asset ratio improved to 34% from 44%, reflecting better financial stability[5][6] - The group maintains a strong financial position with no borrowings and minimal exposure to interest rate fluctuations[28] - The debt-to-asset ratio as of June 30, 2025, was approximately 34%, a decrease from 44% on December 31, 2024, indicating improved financial stability[58] - The company’s liabilities decreased to HKD 177,487,000 from HKD 256,204,000, a reduction of 30.7%[82] Market and Product Development - The company continues to focus on enhancing equipment and strengthening market promotion to capture growth potential in the Chinese wine market[4] - Dynasty Wines currently manufactures and sells over 100 types of wine products, catering to various consumer preferences[4] - The company launched over 100 wine products under the "Wang Chao" brand, catering to diverse consumer preferences in the Chinese wine market[31] - New product launches included the mid-to-high-end "Wang Chao Year of the Snake Red Wine," which integrates Chinese zodiac culture to attract younger consumers[31] - The company introduced the "Tian Yang Tea Wine Series" and "Wang Chao Bai Fu VSOP Brandy" at the 112th National Sugar and Wine Trade Fair, enhancing its product matrix[32] - The group is committed to diversifying its wine products to meet various consumer demands, focusing on low-alcohol and non-alcoholic wines to capture market trends[49] - The Tianxia Winery project in Ningxia is set to launch new products reflecting local characteristics, adhering to strict production standards[49] E-commerce and Marketing - E-commerce sales were expanded through traditional platforms like JD.com and Tmall, as well as innovative channels such as Xiaohongshu and Douyin, improving market penetration among younger consumers[35] - The overall e-commerce sales revenue declined due to market competition, but the company believes online platforms enhance brand promotion and overall business potential[36] - The company is actively promoting AI live streaming models across various channels to enhance brand exposure and sales[51] - The company plans to adjust its e-commerce distribution structure and expand its coverage in the second half of 2025, aiming for sales growth through a multi-store matrix model[51] Employee and Compensation - The total employee compensation and related costs amounted to approximately HKD 23,900,000 as of June 30, 2025, an increase from HKD 23,300,000 in 2024, primarily due to an increase in the number of employees and temporary labor[53] - The company employed 243 staff members as of June 30, 2025, compared to 238 a year earlier, reflecting a commitment to maintaining a skilled workforce[53] - The company reported short-term employee benefits of HKD 1,625,000 for the six months ended June 30, 2025, compared to HKD 1,688,000 for the same period in 2024, a decrease of about 3.7%[139] Governance and Shareholder Information - The board does not recommend any interim dividend payment to shareholders for the six months ending June 30, 2025[62] - As of June 30, 2025, major shareholders include Heng Ming Group Limited with 39.62% and Tianjin Food Group Limited with 42.80% of the voting shares[65] - The company has adhered to the corporate governance code and standards as of June 30, 2025[73] - The company approved a compensation agreement at a special general meeting held on July 25, 2025, indicating ongoing corporate governance activities[142]

Financial Performance - The total revenue for the six months ended June 30, 2025, was HKD 444,500,000, an increase of 17.4% compared to HKD 378,500,000 for the same period in 2024[13]. - Revenue for the six months ended June 30, 2025, was HKD 444,541,000, an increase of 17.4% compared to HKD 378,542,000 for the same period in 2024[56]. - The company reported a loss before tax of HKD 115,901,000, compared to a loss of HKD 36,676,000 in the previous year, indicating a significant increase in losses[56]. - The net loss for the six months ended June 30, 2025, was approximately HKD 115,500,000, compared to a net loss of HKD 36,800,000 for the same period in 2024[17]. - Total comprehensive loss for the six months was HKD 88,441,000, compared to HKD 47,648,000 in the previous year, reflecting a worsening financial position[58]. - Basic and diluted loss per share for the period was HKD 2.02, compared to HKD 0.79 in the same period last year[56]. Revenue Breakdown - The mining business generated revenue of HKD 110,600,000, while the supply chain business saw a decrease in revenue from HKD 328,000,000 to HKD 290,400,000[13]. - Revenue for the supply chain business was HKD 289,842,000, a decrease of 11.3% from HKD 326,800,000 in the previous year[79]. - Revenue from iron ore mining and selection was HKD 110,580,000, with no prior year comparison available[79]. Cost and Expenses - Direct costs and operating expenses increased significantly from HKD 361,500,000 to HKD 421,600,000, and administrative expenses rose from HKD 24,000,000 to HKD 71,000,000[15]. - The company reported total expenses of HKD 118.82 million for the mining project, with operating expenses of HKD 92.87 million and capital expenditures of HKD 25.95 million for the six months ended June 30, 2025[39]. - The company incurred an expected credit loss of HKD 4,773,000 during the period, compared to a reversal of HKD 3,163,000 in the previous year[56]. Assets and Liabilities - The company's total liabilities as of June 30, 2025, were HKD 1,309,321,000, with the supply chain business accounting for HKD 453,593,000[83]. - The company's net asset value decreased to HKD 515,762,000 from HKD 604,203,000, showing a decline in overall equity[61]. - The company's intangible assets increased to HKD 209,000,000, including mining rights valued at HKD 208,600,000[19]. - The company's cash and cash equivalents as of June 30, 2025, were HKD 20,700,000, a slight decrease from HKD 21,700,000 as of December 31, 2024[25]. Financial Ratios - The debt-to-equity ratio increased to 150.2% as of June 30, 2025, compared to 127.9% as of December 31, 2024, primarily due to significant losses during the period[25]. - The current ratio decreased to 0.53 from 0.75, mainly due to a substantial increase in borrowings due within one year[26]. Operational Challenges - The supply chain business faced significant challenges, with revenue slowing or even decreasing compared to the same period last year[8]. - The hotel management and catering services segment recorded a revenue decrease of approximately 14% compared to the same period in 2024, primarily due to a slowdown in consumer recovery and increased competition[9]. - The hotel management and catering services segment continues to incur losses, mainly due to fair value losses on investment properties[9]. - The iron ore mining and processing business experienced downward pressure due to unfavorable price changes and high fixed costs[8]. Strategic Initiatives - The group continues to focus on enhancing credit control measures and monitoring receivables to mitigate financial risks[8]. - The group plans to improve product and service quality in the hotel and catering market to maintain competitiveness[10]. - The group is actively seeking new potential customers to diversify revenue sources in its supply chain business[8]. - The group is implementing prudent and flexible strategies to enhance cost efficiency and optimize operational management[9]. - The group aims to release mining capacity to effectively dilute high fixed costs[8]. Shareholder Information - Major shareholders include Tengle Holdings and Yuerong Holdings, each holding 980,000,000 shares, representing 17.41% of total shares[42]. - Zongchuan Investment Holdings holds 950,000,000 shares, accounting for 16.87% of total shares[42]. - The total number of shares outstanding as of June 30, 2025, is 5,630,000,000[46]. Legal and Financial Obligations - The company is facing a legal lawsuit from the bank for the repayment of the loan, totaling approximately RMB 294,300,000, including principal and interest[49]. - The company is negotiating with the bank to extend the repayment period and aims for an amicable settlement[50]. - The company has ongoing litigation regarding outstanding loans totaling approximately RMB 318,794,000 (approximately HKD 337,954,000)[72]. Employee and Management Changes - The group employed approximately 520 staff as of June 30, 2025, compared to about 280 employees a year earlier, indicating an increase of approximately 85.7%[34]. - Changes in the board of directors include the appointment of new independent non-executive directors and the resignation of several executive directors[45][47]. Investment and Capital Expenditures - Capital expenditures for property, plant, and equipment investments reached approximately HKD 28.2 million for the six months ended June 30, 2025, a significant increase from HKD 2.7 million for the same period in 2024, representing a growth of over 900%[30]. - The company has not disclosed any other individuals or corporations with interests in its shares as of June 30, 2025[43].

股份代號 : 1959 (於開曼群島註冊成立的有限公司) 2025 2025 中期報告 Stock code: 1959 (incorporated in the Cayman Islands with limited liability) INTERIM REPORT 中期報告 Interim Report 2025 目錄 2 公司資料 4 管理層討論及分析 13 其他資料 25 中期簡明綜合損益表 26 中期簡明綜合全面收益表 27 中期簡明綜合財務狀況表 29 中期簡明綜合權益變動表 31 中期簡明綜合現金流量表 33 中期簡明綜合財務資料附註 公司資料 董事會 執行董事 羅厚杰先生 （主席兼行政總裁） 陳華泉先生 李惠芳女士 獨立非執行董事 李偉強先生 李衛寧先生 嚴斐女士 授權代表 羅厚杰先生 陳毅奮先生 聯席公司秘書 陳毅奮先生 梁潔心女士 審核委員會 李偉強先生 （主席） 李衛寧先生 嚴斐女士 薪酬委員會 李衛寧先生 （主席） 陳華泉先生 李偉強先生 提名委員會 羅厚杰先生 （主席） 李衛寧先生 嚴斐女士 註冊辦事處 Cricket Square Hutchins Drive PO Box 26 ...

Financial Performance - Revenue from Continuing Operations for the six months ended June 30, 2025, was RMB 1,089,414, an increase from RMB 493,413 in the same period of 2024[28]. - Gross profit from Continuing Operations rose to RMB 237,156 in the first half of 2025, up from RMB 139,188 in 2024[30]. - Operating profit from Continuing Operations improved to RMB 76,855 in the first half of 2025, compared to an operating loss of RMB 5,195 in the same period of 2024[35]. - Profit before taxation increased to RMB 42,394 in 2025 from RMB 816 in 2024, showing a substantial improvement[128]. - The total comprehensive loss for the period was RMB 193,745 in 2025, compared to a comprehensive income of RMB 77,705 in 2024[129]. - Basic loss per share for the period was RMB (5.08) cents in 2025, down from RMB 1.62 cents in 2024, reflecting a decline in profitability[131]. - The company reported a profit of RMB 24,245 from continuing operations in the first half of 2025, contrasting with a loss of RMB 43,023 in the same period of 2024[129]. - The company experienced a loss from discontinued operations of RMB 150,321 in 2025, compared to a profit of RMB 86,045 in 2024[131]. Coal Production and Trading - For the six months ended June 30, 2025, the Group's coal trading volume reached 3,897,000 tonnes, a significant increase from 2,407,000 tonnes in the same period of 2024, representing a growth of 62.0%[22]. - The Group produced 2,490,000 tonnes of coal from Indonesia, while coal production from China decreased to 1,407,000 tonnes, down from 2,407,000 tonnes in 2024[22]. - The average monthly coal trading volume increased to 650,000 tonnes in the first half of 2025, compared to 401,000 tonnes in the same period of 2024, representing a growth of 62%[28]. - Total washed coal production for the six months ended June 30, 2025, was 2,594,000 tonnes, an increase of 8.7% from 2,387,000 tonnes in the same period of 2024[68]. - The Sumber Daya Energi coal mine in South Kalimantan, Indonesia, produced 2,049,000 tonnes in the first half of 2025, significantly up from 755,000 tonnes in the same period of 2024[65]. Discontinued Operations - The Group completed the disposal of 100% equity interest in the Disposal Group for a consideration of RMB 30,000,000, which held five coal mines in China, effective July 11, 2025[21]. - The operation of the Disposal Group has been classified as discontinued operations, while the remaining operations are classified as continuing operations[21]. - Loss after taxation from Discontinued Operations was RMB 193,734 in the first half of 2025, compared to a profit of RMB 103,830 in the same period of 2024[39]. - Loss from Discontinued Operations increased to RMB 150,321,000 in 2025 from a profit of RMB 86,045,000 in 2024, primarily due to the depletion of coal reserves in China[41]. Strategic Initiatives - The management discussion highlights ongoing efforts in market expansion and potential new strategies for growth in the coal sector[21]. - The Group aims to maintain a reasonable level of gearing and borrowing costs moving forward[38]. - The strategic shift from pure coal production to "resource value management" aims to optimize capital efficiency and maximize shareholder returns[112]. - The Group's innovative model includes attracting strategic investors to take over equity interests after completing mine infrastructure, allowing for premium exits and reinvestment[112]. Assets and Liabilities - Current assets increased significantly to RMB 5,789,135,000 as of June 30, 2025, compared to RMB 2,075,584,000 as of December 31, 2024[74]. - Total liabilities rose to RMB 6,255,543,000 as of June 30, 2025, from RMB 5,143,084,000 as of December 31, 2024[77]. - The gearing ratio increased to 65.8% as of June 30, 2025, compared to 59.6% as of December 31, 2024, reflecting the repayment of loans and the disposal of Discontinued Operations[77]. - The Group's total capital expenditure for Continuing Operations was RMB 397.6 million for the six months ended June 30, 2025, down from RMB 481.4 million in the same period of 2024[78]. Operational Efficiency - The Group's logistics services ensure the delivery of coal to customers worldwide, enhancing operational efficiency[18]. - The management emphasizes the importance of the integrated coal supply chain as a key factor for the Group's success[18]. - The company plans to focus on resource optimization and operational efficiency following the disposal of its Chinese coal mines[56]. - The designed washing capacity of the coal washing system at SDE Mine I is approximately 600,000 tons per month, with plans for a new jigging system to add 300,000 tonnes monthly capacity in the second half of 2025[108]. Employee and Governance - As of June 30, 2025, the Group employed 4,962 employees and has implemented a performance-based reward system[120]. - The Group has complied with the Corporate Governance Code throughout the six months ended June 30, 2025[119].

Market Trends and Opportunities - The healthcare management group reported a significant market trend towards "quality upgrades" and "structural optimization" in the social hospital sector, facing both unprecedented opportunities and severe challenges[18]. - The company noted that policy incentives continue to be released, with increasing emphasis on specialization, digitization, and high-end development paths[18]. - The healthcare sector is experiencing a shift from homogeneous competition to differentiated development, driven by rising consumer demand for high-end medical services and the integration of internet healthcare with traditional services[18]. - The digital transformation in healthcare is becoming essential, with AI-assisted diagnosis, surgical robots, and electronic medical record systems emerging as core competitive technologies[18]. - Investment logic is shifting from scale expansion to value-based healthcare, with capital favoring specialized chains, emerging specialties, and smart healthcare sectors[18]. - The introduction of DRG/DIP payment reforms and international certification requirements has raised industry entry barriers, while differentiated positioning policies provide space for private hospitals to avoid competition with public hospitals[18]. Company Strategy and Focus - The company is adapting to stricter healthcare cost control measures and increasing competition for talent, alongside the expansion of public hospitals[18]. - The company is focusing on expanding its market presence in central and western regions of China, moving away from coastal concentration[18]. - The management team emphasized the importance of compliance capabilities, technological barriers, and brand effects in attracting investment[18]. - The company is committed to enhancing service quality and efficiency through technological empowerment, expanding service boundaries and innovation space[18]. - The group is focusing on a specialized deep cultivation strategy to enhance competitive advantages in key specialty areas[19]. - The group plans to leverage digital transformation, emphasizing AI, big data, and telemedicine to improve healthcare quality and operational efficiency[19]. - The group aims to strengthen its brand through international certifications and transparent operations, integrating brand building with healthcare quality improvement[19]. - The group is actively participating in public health services and charity initiatives, embedding social responsibility into its development strategy[21]. - The group has submitted 30 new technology and project applications, with 13 new technologies passing ethical review, indicating a commitment to research and development[37]. Financial Performance - The group's consolidated revenue for the six months ended June 30, 2025, was RMB 346.8 million, a decrease of RMB 68.4 million or 16.5% compared to RMB 415.2 million for the same period in 2024[24]. - Outpatient visits totaled 717,563, down 31,158 or 4.2% from 748,721 in the previous year[24]. - Inpatient visits decreased to 22,811, a reduction of 6,407 or 21.9% from 29,218 in the previous year[24]. - The average outpatient cost increased by 3.3% to RMB 310.4, while the average inpatient cost decreased by 18.9% to RMB 5,269.5[27]. - The group reported a 15.8% decrease in pharmaceutical sales revenue, totaling RMB 138.8 million compared to RMB 164.7 million in the previous year[38]. - Total revenue decreased by 16.5% from RMB 415.2 million in the six months ended June 30, 2024, to RMB 346.8 million in the six months ended June 30, 2025[41]. - Inpatient medical service revenue fell by 36.7% from RMB 189.9 million to RMB 120.2 million, primarily due to a decrease in inpatient visits and average costs[42]. - Outpatient medical service revenue slightly decreased by 1.0% from RMB 224.9 million to RMB 222.7 million, attributed to a reduction in outpatient visits[42]. - Gross profit decreased by 36.1% from RMB 71.6 million to RMB 45.8 million, with gross margin declining from 17.3% to 13.2%[45]. - Administrative expenses increased by 8.3% from RMB 38.7 million to RMB 41.9 million, mainly due to higher employee benefits and depreciation[47]. - Net financial costs rose from RMB 3.7 million to RMB 4.2 million, primarily due to increased foreign exchange losses[48]. - Income tax expense decreased from RMB 7.8 million to a tax credit of RMB 0.1 million, reflecting a reduction in pre-tax profits[49]. - The company reported a net loss of RMB 0.7 million for the six months ended June 30, 2025, compared to a profit of RMB 20.3 million in the same period of 2024, resulting in a net loss margin of -0.2%[50]. Assets and Liabilities - Current assets increased by 142.0% from RMB 4.6 million to RMB 11.1 million, mainly due to net cash generated from operating activities exceeding cash used in financing activities[52]. - Inventory decreased by 54.6% from RMB 39.6 million to RMB 18.0 million, primarily due to the consumption of stock accumulated for the Spring Festival[53]. - Trade payables decreased from RMB 100.7 million as of December 31, 2024, to RMB 96.0 million as of June 30, 2025, a reduction of RMB 4.7 million due to increased payments during the reporting period[57]. - Accrued expenses and other payables decreased from RMB 107.8 million as of December 31, 2024, to RMB 93.3 million as of June 30, 2025, a decrease of RMB 14.5 million primarily due to increased employee compensation and benefits payments[58]. - The company's debt-to-asset ratio as of June 30, 2025, was 37.3%, down from 40.6% as of December 31, 2024[68]. - The company had no contingent liabilities or guarantees that would significantly impact its financial position or operations as of June 30, 2025[59]. - Lease liabilities related to leased properties amounted to approximately RMB 1.1 million as of June 30, 2025[60]. Cash Flow and Financing Activities - Net cash generated from operating activities increased from RMB 57.3 million for the six months ended June 30, 2024, to RMB 80.7 million for the six months ended June 30, 2025, mainly due to the settlement of receivables from the medical insurance bureau[63]. - Net cash flow from investing activities improved from an outflow of RMB 23.0 million for the six months ended June 30, 2024, to an inflow of RMB 9.0 million for the six months ended June 30, 2025, primarily due to proceeds from the sale of land use rights amounting to RMB 19.1 million[64]. - Net cash used in financing activities increased from RMB 14.0 million for the six months ended June 30, 2024, to RMB 61.3 million for the six months ended June 30, 2025, mainly due to repayment of bank loans of RMB 32.6 million and increased purchases of existing shares under the restricted share unit plan by approximately RMB 17.4 million[65]. - The net increase in cash and cash equivalents was RMB 28.3 million for the six months ended June 30, 2025, compared to RMB 20.4 million for the same period in 2024[62]. - The company did not use any derivative financial instruments to hedge against foreign exchange risks during the reporting period, managing such risks through close monitoring of exchange rate fluctuations[67]. Shareholder Information and Stock Options - Major shareholders include Cao Junming and Sun Mingyan, each holding 384,383,500 shares, representing 64.06% of the total shares[76]. - Rubrical Investment holds 73,595,050 shares, accounting for 12.27% of the total shares[76]. - Sunny Rock has a stake of 310,788,450 shares, which is 51.80% of the total shares[76]. - The total number of shares issued by the company is 600,000,000 as of June 30, 2025[76]. - The stock option plan was approved on June 17, 2020, and is valid for ten years[82]. - The maximum number of shares that can be issued under the stock option plan cannot exceed 30% of the company's issued share capital[85]. - Each participant in the stock option plan is limited to a maximum of 1% of the company's issued share capital in any 12-month period[88]. - Any grant of stock options to connected persons must be approved by independent non-executive directors[89]. - The stock option plan aims to incentivize employees and directors for their contributions to the company[83]. - The company has established a broad participant base for the stock option plan to enhance overall performance and share price[83]. - The total number of shares that may be issued under the share option plan shall not exceed 10% of the shares already issued on the date of listing, amounting to 60,000,000 shares[90]. - The company may seek shareholder approval to expand the general plan limit, but the total number of shares issued under the share option plan cannot exceed 10% of the issued shares as of the approval date[90]. - No share options have been granted, agreed to be granted, exercised, cancelled, or lapsed under the share option plan as of the date of this interim report[94]. Restricted Share Unit Plans - The purpose of the 2022 Restricted Share Unit Plan is to recognize and incentivize participants for their contributions and to attract suitable employees for further development of the group[96]. - Participants in the 2022 Restricted Share Unit Plan include employees or senior officers of the group, including executive, non-executive, and independent non-executive directors[100]. - The total value of shares granted under the plan must exceed HKD 5 million or any higher amount specified by the exchange[97]. - The plan will remain effective for a period of ten years from August 22, 2022, or until an earlier termination date determined by the board or committee[102]. - Unvested restricted share units will be forfeited and automatically cancelled upon certain events, including termination of employment or service[104]. - The company must issue a circular to shareholders regarding any grant of share options to major shareholders or independent non-executive directors, requiring them to abstain from voting[92]. - The exercise price of shares under the share option plan will be determined by the board but shall not be less than HKD 1.00 per option granted[93]. - The total number of existing shares to be purchased under the 2023 Restricted Share Unit Plan will not exceed 5% of the company's issued share capital as of May 9, 2023, which is a maximum of 30,000,000 shares[122]. - The maximum total number of shares involved in granting rewards to selected participants cannot exceed 1% of the company's issued share capital as of May 9, 2023[122]. - As of the date of this interim report, no Restricted Share Units have been granted under the 2023 Restricted Share Unit Plan[123]. - The 2023 Restricted Share Unit Plan was adopted on May 9, 2023, to recognize and incentivize participants for their contributions[110]. - The plan will remain effective for a period of ten years from May 9, 2023, or until an earlier termination date determined by the board or committee[116]. - The committee managing the 2023 Restricted Share Unit Plan has the discretion to grant conditional rights to shares or equivalent cash to selected participants at any time during the plan's term[115]. - Participants in the 2023 Restricted Share Unit Plan include employees of any entity or hospital acquired by the group from the adoption date until the plan's expiration[114]. - The company is prohibited from granting rewards during the period of one month prior to the announcement of financial performance[120]. - The trustee may not hold more than 10% of the total issued shares at any time[122]. - The company will have the right to instruct the trustee to repurchase shares from participants under certain conditions[118]. Global Offering and Utilization of Proceeds - The company raised approximately HKD 264.8 million by issuing 150,000,000 shares at HKD 2.10 per share during the global offering[126]. - As of June 30, 2025, the company has utilized HKD 195.6 million of the net proceeds from the global offering, leaving HKD 69.2 million unutilized[127]. - 29.5% of the net proceeds (HKD 78.0 million) is allocated for the expansion of the company's first-phase building, which is fully utilized[127]. - 26.1% of the net proceeds (HKD 69.2 million) is earmarked for acquiring hospitals to expand the company's business, with no funds utilized yet[127]. Employee Information - Employee costs for the six months ended June 30, 2025, amounted to approximately RMB 107.2 million, a decrease from RMB 118.1 million for the same period in 2024[143]. - The total number of employees as of June 30, 2025, was approximately 1,844, down from 1,953 a year earlier[143]. - The company did not recommend any interim dividend for the six months ended June 30, 2025[142]. - No major investments or acquisitions were made during the reporting period[133]. - The company repurchased a total of 8,962,000 shares at a total cost of approximately HKD 18.90 million during February 2025[132]. - As of June 30, 2025, the unutilized net proceeds from the global offering were deposited as short-term demand deposits[129]. Summary of Financial Metrics - Revenue for the six months ended June 30, 2025, was RMB 346,820,000, a decrease of 16.5% compared to RMB 415,178,000 for the same period in 2024[151]. - Gross profit for the same period was RMB 45,801,000, down 36.1% from RMB 71,621,000 in 2024[151]. - Operating profit decreased significantly to RMB 3,489,000 from RMB 31,833,000, reflecting a decline of 89.0%[151]. - The net loss for the period was RMB 676,000, compared to a profit of RMB 20,263,000 in the previous year[151]. - Total assets as of June 30, 2025, were RMB 894,729,000, down from RMB 974,003,000 at the end of 2024, representing a decrease of 8.1%[154]. - Current assets decreased to RMB 335,963,000 from RMB 384,981,000, a decline of 12.7%[154]. - Cash and cash equivalents increased to RMB 286,780,000 from RMB 258,498,000, an increase of 10.9%[154]. - Total liabilities decreased to RMB 333,918,000 from RMB 395,080,000, a reduction of 15.4%[156]. - The company’s equity attributable to owners decreased to RMB 554,896,000 from RMB 573,005,000, a decline of 3.2%[154]. - The company reported a basic and diluted loss per share of RMB (0.00), compared to earnings per share of RMB 0.04 in the previous year[151]. - For the six months ended June 30, 2025, the operating cash flow generated was RMB 82,485,000, an increase of 21.5% compared to RMB 67,839,000 for the same period in 2024[162]. - The net cash generated from operating activities for the first half of 2025 was RMB 80,653,000, up 40.5% from RMB 57,341,000 in the prior year[162]. - Total revenue for the six months ended June 30, 2025, was RMB 346,820,000, a decrease of 16.5% from RMB 415,178,000 in the same period of 2024[180]. - Revenue from treatment and comprehensive medical services was RMB 204,171,000, down 18.3% from RMB 250,041,000 in the previous year[180]. - The estimated settlement rate for inpatient service revenue was recorded at 86.00%, compared to 93.36% for the year ended December 31, 2024[180]. - Cash and cash equivalents increased by RMB 28,329,000, compared to an increase of RMB 20,404,000 in the same period last year[162]. - The total cash and cash equivalents at the end of the reporting period was RMB 286,780,000, up from RMB 260,203,000 at the end of June 2024[162]. - The company incurred net cash used in financing activities of RMB 61,346,000 for the first half of 2025, compared to RMB 13,962,000 in the same period of 2024[162]. - The company’s borrowings from banks and other financial institutions amounted to RMB 78,400,000, a decrease from RMB 111,000,000 in the previous year[162]. - The company reported a nominal amount of approximately RMB 69,270,000 for inpatient service revenue, expected to be confirmed by the medical insurance bureau in 2026[180]. - The actual final settlement rate for inpatient service revenue in 2024 was 90.46%, a decrease from 98.04% in 2023, resulting in a revenue reduction of RMB 5,037,000 for the six months ending June 30, 2025[181]. - Medical compensation losses amounted to RMB 801,000 for the six months ending June 30, 2025, down from RMB 1,273,000 in the same period of 2024[183]. - Total financial costs for the six months ending June 30, 2025, were RMB 4,198,000, an increase from RMB 3,746,000 in the same period of 2024[184]. - The company reported a loss attributable to owners of RMB 673,000 for the six months ending June 30, 2025, compared to a profit of RMB 20,042,000 in the same period of 2024[192]. - The company did not declare an interim dividend for the six months ending June 30, 2025, consistent with the previous year[194]. - The net book value of property, plant, and equipment as of June 30, 2025, was RMB 496,591,000, down from RMB 525,001,000 at the end of 2024[196]. - The net book value of right-of-use assets as of June 30, 2025, was RMB 54,490,000, unchanged from

Financial Performance - The company reported a revenue of HK$1.2 billion for the last quarter, representing a year-over-year increase of 15%[12]. - The company expects revenue guidance for the next quarter to be between HK$1.3 billion and HK$1.5 billion, indicating a potential growth of 8% to 25%[12]. - The Group achieved total revenue of RMB 1,693.6 million during the Reporting Period, representing a 10.0% increase from RMB 1,539.5 million in the corresponding period of 2024[80]. - The Group recorded an increase of 7.4% in revenue from oil and gas pipes to RMB1,078.7 million, compared to RMB1,004.4 million in the corresponding period of 2024[82]. - Revenue from new energy pipes and special seamless steel pipes increased by 14.9% to RMB614.9 million, up from RMB535.1 million in the same period last year[82]. - Domestic sales revenue grew by 20.2% to RMB1,475.5 million, compared to RMB1,228.0 million in the corresponding period of 2024, attributed to competitive advantages in sales and services[87]. - Overseas sales decreased by 30.0% to RMB218.1 million, down from RMB311.5 million in the same period last year, due to geopolitical tensions and economic policy shifts[89]. - The Group's total gross profit was RMB152.7 million, an increase of RMB28.2 million from RMB124.5 million for the corresponding period of 2024, with a gross profit margin of 9.0%[93]. - The Group's loss narrowed significantly by 78.5% to RMB15.0 million, compared to a loss of RMB69.7 million for the corresponding period of 2024[105]. - The Group reported an adjusted net loss of RMB (8.9) million for the six months ended 30 June 2025, a significant improvement from RMB (55.1) million for the same period in 2024, resulting in an adjusted net loss margin of (0.5%) compared to (3.6%) in 2024[111]. Market Expansion and Strategy - User data showed a growth in active users to 2.5 million, up 20% compared to the previous quarter[12]. - New product launches are anticipated to contribute an additional HK$300 million in revenue over the next fiscal year[12]. - Market expansion plans include entering two new regions in Southeast Asia by Q3 2024, projected to increase market share by 10%[12]. - The Group's strategy aligns with the National Energy Administration's target of producing 10 million tons of hydrogen by 2025, driving demand for special pipes[64]. - The establishment of the Dammam production base in Saudi Arabia is expected to enhance international market penetration and strengthen global brand influence[71]. - The Group is focusing on deepening market expansion in domestic shale gas blocks and offshore oil and gas markets while ensuring timely operations at the Dammam base[71]. Research and Development - The company is investing HK$50 million in R&D for new technologies aimed at enhancing product efficiency[12]. - The Group is committed to developing new products such as economical coal pipes and hydrogen transportation pipes, establishing long-term cooperation with premium domestic and international customers[21]. - The Group's technology R&D has led to breakthroughs in hydrogen/carbon dioxide corrosion-resistant pipes and hydrogen transmission line pipes[69]. - The industry intensified R&D efforts on pipes characterized by high strength, high toughness, long service life, and high precision for energy and material savings[38]. Operational Efficiency and Cost Management - The company has set a target to reduce operational costs by 5% through efficiency improvements in the next fiscal year[12]. - The average profit margin of the industry remained relatively low, pressured by intensified homogeneous competition in low-end products and fluctuations in raw material prices[29]. - The Group's operational efficiency optimization initiative will focus on process innovation and labor efficiency improvement to achieve profitability for conventional products[72]. - The new intelligent tubing production line increased production efficiency by 35% and reduced required manpower by 30%[60]. Environmental and Sustainability Initiatives - The Group received an "A" ESG rating from China Securities Index (CSI) and Wind, ranking 14th within the energy sector, indicating strengthened core competitiveness in green development[49]. - Key energy-saving projects during the reporting period included hydraulic station retrofits and photovoltaic design retrofits, effectively reducing electricity consumption and CO2 emissions[52]. - The Group is committed to reducing unit product carbon emissions to meet EU Carbon Border Adjustment Mechanism requirements through green power substitution technologies[75]. - The Group's focus on energy-saving renovations has not only lowered operating costs but also strengthened its environmental performance[55]. Shareholder and Corporate Governance - The board has approved a dividend payout of HK$0.10 per share, reflecting a commitment to returning value to shareholders[12]. - The Board does not recommend the payment of interim dividends for the reporting period[129]. - The company has complied with all code provisions set out in part 2 of the Corporate Governance Code during the reporting period[137]. - The total number of issued Shares as of June 30, 2025, is 1,505,868,000[3]. Employee and Talent Development - The Group had a total of 1,934 employees as of 30 June 2025, with total staff costs amounting to RMB 131.5 million, compared to RMB 119.1 million in the same period of 2024[120]. - The Group is enhancing talent development through practical training linked to new production line projects, improving the skills of frontline operators[53]. Financial Position and Capital Expenditure - Capital expenditure during the reporting period was RMB 505.8 million, a substantial increase from RMB 158.4 million in the corresponding period of 2024, primarily due to the Phase Two Expansion[112]. - As of 30 June 2025, the Group's cash at bank and on hand amounted to RMB 355.5 million, down from RMB 412.1 million as of 31 December 2024[114]. - The Group's interest-bearing borrowings increased to RMB 2,522.9 million as of 30 June 2025, up from RMB 2,212.6 million at the end of 2024, with long-term borrowings rising to RMB 1,395.6 million[117]. - The gearing ratio increased to 166.1% as of 30 June 2025, up 29.2 percentage points from 136.9% at the end of 2024, attributed to increased borrowings and decreased equity due to losses[118]. - The current ratio improved from 1.02 as of 31 December 2024 to 1.15 as of 30 June 2025, indicating better short-term financial health[119].

(股份代號: 06963) （於中華人民共和國註冊成立的股份有限公司） 中期報告 陽光保險集團股份有限公 司 中期報告 2025 陽光保險集團股份有限公司 | 2025 年中期報告 01 | 釋義 | 2 | | --- | --- | | 關於我們 | | | 公司資料 | 7 | | 業績摘要 | 9 | | 管理層討論與分析 | | | 業務概覽 | 11 | | 業績分析 | 21 | | 專項分析 | 44 | | 重要事項 | 47 | | 未來展望 | 48 | | 內含價值 | 50 | | 其他資料 | 57 | | 財務報表及其他 | | | 獨立審閱報告 | 71 | | 合併財務報表及附註 | 72 | 02 釋義 釋義 「公司章程」或「章程」 指 《陽光保險集團股份有限公司章程》 「董事會」 指 本公司董事會 「監事會」 指 本公司監事會 「《企業管治守則》」 指 上市規則附錄C1所載的企業管治守則 「中國銀保監會」 指 中國銀行保險監督管理委員會，中國銀監會與中國保監會按國務 院於2018年3月24日發佈的《國務院關於機構設置的通知》（國發 [2018]6號）合併成為的監管機構，以 ...

Financial Performance - For the six months ending June 30, 2025, the group recorded an unaudited net loss of approximately RMB 4.45 million, compared to an unaudited net loss of approximately RMB 5.51 million for the same period in 2024[3]. - The unaudited total revenue for the six months ending June 30, 2025, was approximately RMB 5.59 million, representing about 65% of the unaudited total revenue of approximately RMB 8.66 million for the same period in 2024[3]. - The total profit (loss) for the six months ending June 30, 2025, was a loss of RMB 4.45 million, an improvement from a loss of RMB 5.51 million for the same period in 2024[8]. - Net loss for the first half of 2025 was RMB 4,449,140.12, an improvement from a net loss of RMB 5,514,962.85 in the same period of 2024, representing a reduction of approximately 19.3%[9]. - Total revenue for the first half of 2025 was 5,585,018.75, a decrease of 35.5% compared to 8,659,011.97 in the same period of 2024[28]. Assets and Liabilities - As of June 30, 2025, total assets amounted to RMB 48.64 million, a decrease from RMB 49.99 million as of December 31, 2024[5]. - Current liabilities totaled RMB 89.32 million as of June 30, 2025, compared to RMB 86.22 million as of December 31, 2024[6]. - The total liabilities increased to RMB 99.85 million as of June 30, 2025, from RMB 96.76 million as of December 31, 2024[6]. - The total equity attributable to shareholders of the parent company was negative RMB 53.70 million as of June 30, 2025, compared to negative RMB 49.32 million as of December 31, 2024[6]. - The total assets as of June 30, 2025, were 48,643,114.58, a slight decrease from 49,999,190.96 as of December 31, 2024[26]. - Total liabilities as of June 30, 2025, were 99,851,437.85, an increase from 96,758,374.11 as of December 31, 2024[26]. Cash Flow - Cash flow from operating activities showed a net outflow of RMB 1,428,565.94 in 2025, compared to a net outflow of RMB 3,992,620.50 in 2024, indicating an improvement of approximately 64.3%[11]. - Cash flow from investing activities resulted in a net outflow of RMB 27,840.00 in 2025, down from a net inflow of RMB 475,750.00 in 2024, marking a significant shift in investment strategy[12]. - Cash flow from financing activities recorded a net outflow of RMB 73,431.52 in 2025, compared to a net inflow of RMB 2,954,584.50 in 2024, indicating a change in financing approach[13]. - Cash and cash equivalents at the end of June 30, 2025, totaled approximately RMB 1.33 million, an increase from RMB 1.19 million at the end of June 30, 2024[46]. Expenses - Operating costs for the six months ending June 30, 2025, were RMB 10.04 million, down from RMB 14.47 million for the same period in 2024[8]. - Research and development expenses for the six months ending June 30, 2025, were RMB 0.85 million, compared to RMB 1.00 million for the same period in 2024[8]. - Total sales expenses decreased to 1,052,649.29 in the first half of 2025, down 30.3% from 1,509,091.26 in the first half of 2024[30]. - Management expenses for the first half of 2025 were 4,540,965.48, a significant reduction of 31.7% compared to 6,625,145.97 in the same period of 2024[31]. - Financial expenses decreased to 90,407.85 in the first half of 2025, down 41.4% from 154,367.75 in the same period of 2024[33]. Shareholder Information - The company’s registered capital and paid-in capital are both RMB 189.7629 million[16]. - The company has a significant concentration of ownership, with the top five shareholders holding over 70% of the total issued shares[70]. - Tianan Enterprise holds 328,363,637 domestic shares, representing approximately 26.23% of the total issued shares[70]. - Chen Jing holds a total of 485,832,335 domestic shares, which accounts for 38.81% of the total issued shares[70]. - Gao Xiang Investment holds 254,844,804 domestic shares, representing about 20.36% of the total issued shares[70]. Corporate Governance - The company has adopted and complied with the corporate governance code as per GEM listing rules, ensuring transparency and accountability[81]. - The company has revised its articles of association to eliminate the supervisory board, effective from June 28, 2025[82]. - The company’s audit committee will now exercise the powers and functions previously held by the supervisory board following its dissolution[83]. - The audit committee reviewed the unaudited condensed consolidated results for the six months ended June 30, 2025, and confirmed compliance with applicable accounting standards and GEM listing rules[88]. - The company has allocated sufficient resources and training to ensure ongoing compliance with relevant laws and regulations[84]. Business Operations - The group has actively participated in the procurement projects for lens antennas and has secured new orders from mobile communication operators in Heilongjiang and Inner Mongolia, starting supply[55]. - The group plans to explore new sales models for lens WiFi products to attract new customer segments and improve performance[55]. - The group will continue to enrich its metamaterials product series and explore applications in various fields, including mobile communication and smart cities[55]. - The company has not issued new shares during the reporting period, maintaining the total share capital at RMB 189.7629 million[27]. - There were no major acquisitions or disposals of subsidiaries or associated companies during the six months ended June 30, 2025[60]. Miscellaneous - The company has no significant contingent liabilities as of June 30, 2025[64]. - No significant events have occurred post-reporting period that would materially impact the company's operations and financial performance[76]. - There were no significant litigations or arbitrations involving the company for the six months ended June 30, 2025[89]. - The company did not engage in any buybacks, sales, or redemptions of its listed securities during the six months ending June 30, 2025[78].

融心砥礪 篤定前行 Z:\09. IR\166335 Ronshine China IR25\Cover\Ronshine China IR25_FullCover 目錄 | 公司資料 | 2 | | --- | --- | | 財務摘要 | 4 | | 業務回顧及展望 | 5 | | 管理層討論及分析 | 11 | | 企業管治及其他資料 | 27 | | 簡明合併收益表 | 33 | | 簡明合併全面收益表 | 34 | | 簡明合併資產負債表 | 35 | | 簡明合併權益變動表 | 37 | | 簡明合併現金流量表 | 39 | | 簡明合併財務報表附註 | 41 | 3 融信中國控股有限公司 二零二五年中期報告 融信中國控股有限公司 二零二五年中期報告 2 公司資料 董事會 執行董事 歐宗洪先生 （主席兼行政總裁） 余麗娟女士 曾飛燕女士 吳建興先生 非執行董事 李樹培先生 獨立非執行董事 任煜男先生 阮偉鋒先生 馮東成先生 （於二零二五年三月七日獲委任） 審核委員會 馮東成先生 （主席）（於二零二五年三月七日獲委任） 任煜男先生 阮偉鋒先生 薪酬委員會 任煜男先生 （主席） 馮東成先生 （於二零二 ...

中期報告 2025 (於開曼群島註冊成立的有限公司) 股份代號: 6128 美國紐交所股份代號: GRFX 目錄 2 財務摘要 3 公司資料 4 未經審核中期簡明綜合損益表 5 未經審核中期簡明綜合全面收益表 6 未經審核中期簡明綜合財務狀況表 8 未經審核中期簡明綜合權益變動表 10 未經審核中期簡明綜合現金流量表 11 未經審核中期簡明綜合財務報表附註 34 管理層討論與分析 41 其他資料 財務摘要 財務摘要 | | | 截至六月三十日止六個月 | | | --- | --- | --- | --- | | 業績 | 二零二五年 | 二零二四年 | 變動 | | | 千港元 | 千港元 | | | 收入 | 76,835 | 93,742 | (18)% | | 石墨烯產品 | 48,389 | 61,489 | (21)% | | 景觀設計 | 28,446 | 32,253 | (12)% | | 經調整分部EBITDA* | 9,525 | 4,682 | 103% | | 石墨烯產品 | 10,563 | 7,374 | 43% | | 景觀設計 | (1,038) | (2,692) | (6 ...